This study involves minor participants (children aged 8-16 years with autism spectrum disorder), a vulnerable population. Individual participant data (IPD) contains sensitive clinical, behavioral, and family-related personal information, and the protection of participants' privacy and data security is the primary principle. The study's informed consent form and approved ethical review protocol did not pre-notify participants and their guardians that individual-level data would be shared with third parties. In addition, the data are subject to relevant laws and regulations on personal information protection in China, which restrict the sharing of individual sensitive personal data of minors. Aggregate-level study results will be published in peer-reviewed journals, and relevant statistical analysis code will be available from the corresponding author upon reasonable request to ensure the reproducibility of the results, while fully protecting the privacy of participants.